rs368097770
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_004970.3(IGFALS):c.634G>A(p.Ala212Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000506 in 1,548,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004970.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGFALS | NM_004970.3 | c.634G>A | p.Ala212Thr | missense_variant | 2/2 | ENST00000215539.4 | NP_004961.1 | |
IGFALS | NM_001146006.2 | c.748G>A | p.Ala250Thr | missense_variant | 2/2 | NP_001139478.1 | ||
IGFALS | NR_027389.1 | n.688G>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFALS | ENST00000215539.4 | c.634G>A | p.Ala212Thr | missense_variant | 2/2 | 1 | NM_004970.3 | ENSP00000215539 | P1 | |
IGFALS | ENST00000415638.3 | c.748G>A | p.Ala250Thr | missense_variant | 2/2 | 2 | ENSP00000416683 | |||
SPSB3 | ENST00000569769.1 | c.-13+1853G>A | intron_variant | 3 | ENSP00000455098 | |||||
IGFALS | ENST00000568221.1 | downstream_gene_variant | 4 | ENSP00000456923 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152210Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000378 AC: 56AN: 147970Hom.: 0 AF XY: 0.000313 AC XY: 25AN XY: 79866
GnomAD4 exome AF: 0.000527 AC: 736AN: 1396078Hom.: 0 Cov.: 32 AF XY: 0.000502 AC XY: 346AN XY: 689804
GnomAD4 genome AF: 0.000315 AC: 48AN: 152328Hom.: 0 Cov.: 34 AF XY: 0.000215 AC XY: 16AN XY: 74490
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2022 | The c.634G>A (p.A212T) alteration is located in exon 2 (coding exon 2) of the IGFALS gene. This alteration results from a G to A substitution at nucleotide position 634, causing the alanine (A) at amino acid position 212 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 25, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Short stature due to primary acid-labile subunit deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Sep 05, 2017 | BS1, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at